Opinion: Share Diverse Genomic Data

Personalized interpretation is the next frontier in clinical genomics, but we won’t get there without sharing data representing all ethnic groups.

Written byRamon Felciano
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

ISTOCK, JEZPERKLAUZENIn just 15 years, we have gone from the first rough draft of the human genome to early successes in using genomic information to improve patient care. The rate of progress has been astonishing. But we still have a long way to go before we realize the full potential of routine genome sequencing in the clinic. Perhaps the single most important element we need right now is better context for genome interpretation—access to the relevant data that help medical geneticists and other healthcare professionals pinpoint disease-causing DNA variants, and translate DNA variants into actionable insights that help ensure each patient receives the best course of treatment.

That’s why a collection of academic and commercial organizations, my company among them, banded together to form the Allele Frequency Community, a group we believe will help deliver critical context needed for sequence interpretation to the biomedical community—all built upon effective, responsible data sharing. This community-driven effort is designed to make clinically useful genomic information broadly available to researchers and clinicians alike.

Current genomic databases are extremely valuable for research, but often lack a diverse representation of ethnic groups from around the globe. Clinical geneticists trying to determine whether a particular variant is relevant for a patient from one of these underrepresented ethnic groups face a serious challenge, as simple approaches can yield a number of “red herring” variants thought to be disease-causing that are ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies